Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.
With the falling cost of genome sequencing, it comes as no surprise that there is a growing interest in expanding the availability and accessibility of genomics via consumer testing. Now, Nebula Genomics has entered the market by launching a comprehensive at-home test that analyses the whole genome for just $299.
The epigenetics of people who use exclusively use vape pens versus cigarettes has been examined for the first time. Key […]
FLG: Can you introduce yourself and your work? I’m Sandra Smieszek and I’m the Head of Genetics at Vanda Pharmaceuticals […]
Neil Walker is IT Lead at the NIHR BioResource, a richly phenotyped and genotyped panel of participants who can be […]
Professor of Bioinformatics, Director, the Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of London Co-Investigator, Health […]
Ernst Hafen, PhD, is a Professor of Systems Genetics at ETH Zurich (Institute of Molecular Systems Biology) and former President […]
Dennis graduated from the University of British Columbia (Vancouver, Canada) with a BSc in Computer Science, Microbiology and Immunology. He […]
Dr Watson is a HCPC registered Clinical Scientist leading NHS research and development activities in the Translational Genomics Unit (a […]
Chris has studied cancer genetics for the best part of ten years. Previously he studied the genetics and pharmacogenetics of […]